PMID 40700207

Research
All papers

High-Intensity Interval Training Improves Cardiovascular Fitness and Induces Left-Ventricular Hypertrophy During Off-Season

Question

Does a 7-week off-season running HIIT program improve fitness, performance, and cardiac morphology in young amateur dinghy sailors?

Summary

In eight young amateur sailors, 7 weeks of supervised running HIIT during the off-season improved VO2peak and running performance and increased some cardiac wall-thickness measures. The study was small and uncontrolled, so the cardiac findings should be treated as preliminary athletic adaptation evidence.

Methodology

  • Young amateur dinghy sailors
  • 8 participants.
  • Indoor-track running.
  • Work intervals: 200 to 1000 m repeats.
  • Recovery: Sitting or slow walking recovery.
  • Intensity: 95-145% of 2000 m velocity depending on distance.
  • 36 to 106 min depending on week.
  • 3 sessions/week.
  • 7 weeks.
  • Single-arm longitudinal intervention study
  • VO2peak, Running performance, and Cardiac morphology were tracked.

Outcomes

VO2peak

VO2peak increased after 7 weeks of running HIIT.

44.1 +/- 7.2 to 46.2 +/- 8.3 mL/kg/min, p=0.02.

Improved

Performance

Running performance improved in the 200 m and 2000 m tests.

Exact values were reported in the article tables; both performance tests improved.

Improved

Cardiac structure

Left atrial diameter and LV wall-thickness measures increased, while ejection fraction stayed normal and unchanged.

LA diameter 32.0 to 33.5 mm, p=0.01; LV posterior wall 7.5 to 8.2 mm, p=0.01; septum 7.6 to 8.6 mm, p=0.02.

Mixed

Insights

  • Performance-based pacing can scale running intervals for athletes.
  • High adherence may reflect supervised team-like athlete context.
  • Cardiac adaptation claims require controlled replication.

Limitations

  • Small sample
  • No control group
  • Athlete-only population
  • Only two female participants
  • Short duration
  • Cycle test used after running training

Safety

  • No adverse events or injuries were reported.
  • No detailed adverse-event monitoring method was described.